Amanta Healthcare IPO GMP Grey Market Premium
Amanta Healthcare IPO GMP is closed at ₹10 on 9 Sept 2025, estimating a profit of +7.94%. The IPO was highly oversubscribed 82.6x times, reflecting a strong value of its shares over investors. Shares of Amanta Healthcare IPO are listed on both BSE and NSE exchanges on 9 Sept successfully. The highest grey market premium of Amanta Healthcare IPO was ₹30, estimating +23.81% returns on 30 Aug 2025. The lowest GMP ever recorded was ₹8 on 4 Sept 2024, estimating just +6.35% profit.
| Lowest GMP | Present GMP | Highest GMP | Listing Gains |
|---|---|---|---|
| ₹8 | ₹10 | ₹30 | ₹9 |
| +6.35% | +7.94% | +23.81% | +7.14% |
Amanta Healthcare IPO is a Bookbuilding IPO, issuing 1 crore shares worth up to ₹126 Cr to the public. On NSE, shares of Amanta Healthcare IPO are listed at ₹135, giving a profit of +7.14% over the IPO issue price of ₹126. On the BSE, the same IPO shares are listed at ₹134.90, gain of 7.06%. As per the last available GMP data, Amanta Healthcare IPO GMP is ₹10, but the real listing premium was ₹9, which is slightly lower and acceptable. Hence, the iporeturns.com Amanta Healthcare IPO GMP accuracy is 92.6%
Amanta Healthcare IPO GMP Live Tracker
The following table consists of live updates of Amanta Healthcare IPO GMP of last 10 days from the grey market. Investors can check the GMP trends of the IPO shares to understand its demand and decide whether to invest in the Amanta Healthcare IPO or to avoid it.
| GMP Date | GMP [₹126] | Sub2 Sauda Rate | Est. Profit | Est. Listing Price | IPO Event |
|---|---|---|---|---|---|
| 9-Sept | ₹10 | ₹800/11200 | +7.94% | ₹136 | Listing |
| 8-Sept | ₹10 | ₹800/11200 | +7.94% | ₹136 | |
| 7-Sept | ₹10 | ₹800/11200 | +7.94% | ₹136 | |
| 6-Sept | ₹10 | ₹800/11200 | +7.94% | ₹136 | |
| 5-Sept | ₹10 | ₹800/11200 | +7.94% | ₹136 | |
| 4-Sept | ₹8 | ₹800/11200 | +6.35% | ₹134 | Allotment |
| 3-Sept | ₹10 | ₹1000/12000 | +7.94% | ₹136 | Close |
| 2-Sept | ₹15 | ₹1500/15000 | +11.90% | ₹141 | |
| 1-Sept | ₹25 | ₹2300/32000 | +19.84% | ₹151 | Open |
| 31-Aug | ₹25 | ₹2300/32000 | +19.84% | ₹151 | |
| 30-Aug | ₹30 | ₹2500/35000 | +23.81% | ₹156 | |
| 29-Aug | ₹25 | ₹2400/32000 | +19.84% | ₹151 | |
| 28-Aug | ₹20 | ₹2400/32000 | +15.87% | ₹146 |
The information on iporeturns.com regarding Amanta Healthcare IPO is for educational purposes only and does not constitute investment advice or guarantee returns. Investing in IPOs, including Grey Market Premium (GMP) data, carries significant risk, and past performance is not indicative of future results. Users are solely responsible for their investment decisions. iporeturns.com and its owners disclaim all liability for any losses.
What is Amanta Healthcare IPO GMP or Grey Market Premium?
Amanta Healthcare IPO Grey Market Premium is the premium price paid by investors in grey market for each Amanta Healthcare IPO share. The GMP price is the price at which an IPO share is traded in an unregulated and unofficial grey market just before listing of its shares. The grey market premium of Amanta Healthcare IPO reflects its demand factor among the investor community. If the GMP is positive, it signals a profitable listing on its listing date. If the GMP is low or negative, then it is expected to be listed at loss or discount and may be avoided by investors
In Amanta Healthcare IPO case, the latest available ₹10 over its issue price of ₹126. It is anticipated that, Amanta Healthcare IPO shares are expected to list at a premium of +7.94% Profit. However, on listing day, shares of Amanta Healthcare are listed at slightly lower price of ₹135 only. Hence the Amanta Healthcare IPO GMP prediction is valid and accuracy is 92.6%.
However it should be noted that the Amanta Healthcare IPO GMP could be highly volatile and risky. Therefore, before to investing, please consider all factors of the Amanta Healthcare IPO and make correct decision before investing in it.
Amanta Healthcare IPO GMP Accuracy: 92.6%
The following table gives complete overview of grey market premium accuracy in terms of Direction Prediction, Return Magnitude and Price Estimation. As per the metrics, the iporeturns GMP accuracy of Amanta Healthcare IPO is 85%.
| Accuracy Component | Result | Score | Details |
|---|---|---|---|
| Direction Prediction | Correct | 100% | Predicted gain, got positive listing (+7.14%) |
| Return Magnitude | Overestimated | 75% | Predicted +7.94% but actual was +7.14% |
| Price Estimation | Very Close | 92.6% | ₹136 vs ₹135 (₹1 overestimate) |
| iporeturns GMP Accuracy | Excellent Performance | 92.6% | Correctly predicted positive direction with very close price estimate |
Amanta Healthcare IPO Important Dates
| IPO Event | Date |
|---|---|
| IPO Open Date | 1-Sept-2025 |
| IPO Close Date | 3-Sept-2025 |
| Allotment Date | 4-Sept-2025 |
| Refund Date | 8-Sept-2025 |
| Credit to DEMAT | 8-Sept-2025 |
| IPO Listing Date | 9-Sept-2025 |
Disclaimer: The information provided about Amanta Healthcare IPO and its grey market premium (₹10) is for educational and informational purposes only. It should not be considered financial advice or a recommendation to invest. Please consult a qualified financial advisor before making any investment decisions. Investing in the Amanta Healthcare IPO or stock market, including IPOs, carries risks, and readers act at their own risk.
About Amanta Healthcare Limited Company
Incorporated in December 1994, Amanta Healthcare Limited is a well-established pharmaceutical company with over three decades of experience in manufacturing sterile liquid formulations. Based in Ahmedabad, Gujarat, the company has emerged as India’s most versatile manufacturer and marketer of sterile dosages in Aseptic Blow-Fill-Seal (BFS) and Injection Stretch Blow Moulding (ISBM) technologies.
Amanta Healthcare Limited operates as a pharmaceutical company specializing in sterile formulations, fluid therapy, ophthalmics, diluents, respules, and injections, as well as medical devices and respiratory solutions. The company’s comprehensive product range includes Formulations, Fluid Therapy, Ophthalmics, Respiratory Solutions, Medical Device (CE Mark), Diluents and Injections.
Amanta Healthcare operates from a state-of-the-art manufacturing facility spanning 66,852 square meters in Gujarat, featuring multiple production lines for sterile liquid manufacturing that support diverse fill volumes and closure systems. The company has adopted modern ISBM and sophisticated Aseptic BFS technology, with ISO certified and cGMP compliant facilities capable of handling manufacturing and packaging of Sterile Liquid Parenterals from 5 ml to 1000 ml.
The company’s facilities have been accredited with approvals from TGA – Australia and MCC – South Africa, demonstrating its commitment to international quality standards and regulatory compliance.
Amanta Healthcare IPO GMP Grey Market Premium FAQs
-
What is Amanta Healthcare IPO Grey Market Premium Today?
The last updated Amanta Healthcare IPO Grey Market Premium was ₹10, indicating an estimated +7.94% listing gain.
-
What is highest and lowest Amanta Healthcare IPO GMP rates?
Highest GMP: ₹30 (expected +23.81% profit)
Lowest GMP: ₹8 (expected +6.35% profit) -
What is Amanta Healthcare IPO estimated listing price?
Based on the last GMP of ₹10 and issue price of ₹126, the expected listing price was around ₹135, estimating a profit of +7.94%.
-
What was the actual listing price of Amanta Healthcare IPO?
On NSE, shares of Amanta Healthcare IPO are listed at ₹135, giving a profit of +7.14% over the IPO issue price of ₹126. On the BSE, the same IPO shares are listed at ₹134.90, gain of 7.06%.
-
How accurate was the Amanta Healthcare IPO GMP prediction?
The GMP prediction had an accuracy score of 92.6%, as correctly predicted positive direction with very close price estimate. Predicted +7.94% but actual was +7.14%
-
What is the Amanta Healthcare IPO Subscription rate?
Amanta Healthcare is oversubscribed 82.6x times, showing strong investor demand.